Patient-Centric AFib Screening

Early detection of arrhythmias is possible with Kardia screening program, a home-based screening program that is easy for at-risk members to follow, for short or long-term monitoring.

AFib Prevalence is significantly undetected

40%

of AFib patients are asymptomatic

20%

of patients’ first clinical manifestation of AFib is stroke²

$8.7k

AFib can increase annual health care costs by $8700 per patient³

KardiaMobile®

Proven to detect undiagnosed AFib & reduce total cost of care⁴

#1 patient-preferred personal ECG brand with high satisfaction

Easy to use for long-term monitoring with no uncomfortable patches or wires

FDA-cleared, instant heart rhythm determination gives patients peace of mind

Telecardiology coverage nationwide with same-day appointments available

KardiaMobile® detected more AFib than routine care

REHEARSE-AF Study found a nearly 4x increase in AFib detection in KardiaMobile group compared to routine care alone.⁴

RCT (n=1001) using KardiaMobile for AFib screening
Patients aged ≥ 65 with CHADS-VASc score ≥ 2
ECGs captured 2x weekly over 12 months (or if symptomatic)

How It Works

Step 1

At-risk members enroll in program and receive KardiaMobile ECG device for real-time monitoring.

Step 2

If possible arrhythmia detected, AliveCor cardiac tech reviews ECG within 24 hrs and sends to cardiologist for confirmation.

Step 3

Member receives virtual visit with AliveCor-affiliated cardiologist to make an appropriate diagnosis, with guidance to appropriate health plan resources.

Offer an innovative supplemental benefit program designed to improve risk adjustment accuracy and support quality initiatives

References

Boriani, et al. "Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry." Am J Med vol. 128,5 (2015): 509-518.2.
Tayal, A Het al. "Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke." Neurology vol. 71,21 (2008): 1696-701.
Calkins, Het al. "HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation." Heart Rhythm vol. 14, 10 (2017): e275-444.
Halcox, J P Jet al. "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study." Circulation vol. 136,19 (2017): 1784-1794.